/Companies

Valid

1 known investors

Find your way into Valid

Sign up to see every warm intro you have to Valid

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Valid team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

VALID builds human iPSC-derived co-culture disease models and pairs them with automated high-throughput perturbation screening and multimodal measurement (imaging, RNA-seq, proteomics) to generate AI-ready biological data for drug discovery. Its platform aims to produce more human-relevant, predictive hypotheses and targets for pharmaceutical development.

Founders & leadership

TA
Tim AhfeldtCo-Founder & CEO
JL
Josh LamsteinCo-Founder & CFO/COO
OW
Ole WiskowHead of Platform
RM
Rob MocciaHead of AI and Data
TA
Tony AsherChief Information Security Officer

Investors · 1

Frequently asked questions

What does Valid do?
VALID builds human iPSC-derived co-culture disease models and pairs them with automated high-throughput perturbation screening and multimodal measurement (imaging, RNA-seq, proteomics) to generate AI-ready biological data for drug discovery. Its platform aims to produce more human-relevant, predictive hypotheses and targets for pharmaceutical development.
Who are Valid's investors?
Valid's investors include Amino Collective.